Stay updated on Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the conditions section, and the Genetic and Rare Diseases Information Center resource was added under Resources.
    Difference
    0.1%
    Check dated 2026-02-18T03:51:55.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    There is a new revision label 'Revision: v3.4.2' on the page and the previous notice about government funding status and operating updates has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:40:03.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-03T23:56:44.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated QC-related fields (Last Update Submitted that Met QC Criteria) and policy text (No FEAR Act Data) with a new revision tag (v3.4.0). Deletions remove the prior QC wording (Last Update Submitted that met QC Criteria; No FEAR Act data; v3.3.4); To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:17:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a version update from v3.3.3 to v3.3.4 with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:12:56.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a consolidated Locations section with expanded study sites across multiple US states and other countries, and removed the previous per-state location entries (and the HHS Vulnerability Disclosure link) to streamline navigation.
    Difference
    1%
    Check dated 2025-12-23T09:13:07.000Z thumbnail image

Stay in the know with updates to Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.